The Prevalence, Morbidities, and Treatments of Insomnia

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|6|1|3-16

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.6, Iss.1, 2007-02, pp. : 3-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Primary and Secondary Insomnia: Prevalence, Causes and Current Therapeutics

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Iss. 2, 2004-06 ,pp. : 119-137

Bentham Science Publishers

Access to resources Recommend Favorite

Zolpidem for insomnia

By Greenblatt David J   Roth Thomas  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 6, 2012-04 ,pp. : 879-893

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy of insomnia

By Ioachimescu Octavian C   El-Solh Ali A  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 9, 2012-06 ,pp. : 1243-1260

Informa Healthcare

Access to resources Recommend Favorite

Tasimelteon for insomnia

By Lankford D Alan  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 7, 2011-07 ,pp. : 987-993

Informa Healthcare

Access to resources Recommend Favorite

Neutralizing Antibodies to Interferon-β and other Immunological Treatments for Multiple Sclerosis: Prevalence and Impact on Outcomes

By Deisenhammer Florian  

CNS Drugs, Vol. 23, Iss. 5, 2009-05 ,pp. : 379-396

Adis International

Access to resources Recommend Favorite